Select Page

General Chemistry

Scalable Solutions for General Chemistry Screening

Since the Protecting Access to Medicare Act of 2014 (PAMA), clinical laboratories have been tasked to do more with less due to an increase in finical pressure. Over the next 3 years, clinical laboratories will face Medicare cuts of up to 30% due to the Centers for Medicare and Medicaid Services’ (CMS) new fee schedule.1 With the continuous decline in reimbursements, it is necessary for clinical laboratories to implement cost-reduction strategies, assuring their success.

Three ways we can help lower your total cost of ownership:

  • Decreasing your monthly reagent spend by offering your laboratory analyzers that require minimal reagent usage per test
  • Lowering your labor costs with and increasing your efficiency with our broad range of moderately complex general chemistry assays
  • Decreasing your reagent scrap rate and achieving superior lot-to-lot traceability and precise performance with our high quality general chemistry reagents, calibrators, controls and standards

 

Learn More About Our Superior Solutions:

References:

  1. CMS.gov. (2020).Clinical Laboratory Fee Schedule. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched